These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17241858)
1. Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies. Ohlsson B; Veress B; Janciauskiene S; Montgomery A; Haglund M; Wallmark A Gastroenterology; 2007 Jan; 132(1):45-51. PubMed ID: 17241858 [TBL] [Abstract][Full Text] [Related]
2. Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility. Hammar O; Ohlsson B; Veress B; Alm R; Fredrikson GN; Montgomery A Scand J Gastroenterol; 2012 Oct; 47(10):1165-73. PubMed ID: 22835010 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization. Hammar O; Roth B; Bengtsson M; Mandl T; Ohlsson B BMC Pregnancy Childbirth; 2013 Nov; 13():201. PubMed ID: 24191889 [TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract. Sand E; Voss U; Hammar O; Alm R; Fredrikson GN; Ohlsson B; Ekblad E Cell Tissue Res; 2013 Mar; 351(3):521-34. PubMed ID: 23254679 [TBL] [Abstract][Full Text] [Related]
5. [Chronic intestinal pseudo-obstruction and anti-Hu syndrome: 13 years of follow-up without neoplasia]. Amiot A; Joly F; Messing B; Sokol H; Lavergne-Slove A; Delattre JY; Bouhnik Y Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):51-5. PubMed ID: 18341976 [TBL] [Abstract][Full Text] [Related]
6. Structural and functional consequences of buserelin-induced enteric neuropathy in rat. Sand E; Roth B; Weström B; Bonn P; Ekblad E; Ohlsson B BMC Gastroenterol; 2014 Dec; 14():209. PubMed ID: 25496312 [TBL] [Abstract][Full Text] [Related]
7. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. Ohlsson B; Ekblad E; Veress B; Montgomery A; Janciauskiene S BMC Gastroenterol; 2010 May; 10():48. PubMed ID: 20487533 [TBL] [Abstract][Full Text] [Related]
8. Luteinizing hormone receptors are expressed in rat myenteric neurons and mediate neuronal loss. Sand E; Voss U; Ohlsson B; Ekblad E Auton Neurosci; 2015 Dec; 193():104-7. PubMed ID: 26480825 [TBL] [Abstract][Full Text] [Related]
9. The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control study. Amiot A; Cazals-Hatem D; Joly F; Lavergne-Slove A; Peuchmaur M; Bouhnik Y; Bedossa P; Messing B Am J Surg Pathol; 2009 May; 33(5):749-58. PubMed ID: 19252433 [TBL] [Abstract][Full Text] [Related]
10. [Chronic idiopathic intestinal pseudo-obstruction: visceral myopathy. Report of 4 cases]. de Pini AF; de Dávila MT; Marín A; Guastavino E; Ruiz JA; De Rosa S Acta Gastroenterol Latinoam; 1993; 23(4):239-43. PubMed ID: 8203187 [TBL] [Abstract][Full Text] [Related]
11. Four cases with chronic intestinal pseudo-obstruction due to hollow visceral myopathy. Arslan M; Bayraktar Y; Oksuzoglu G; Ozdemir A; Sokmensuer C; Yagmurdur MC; Soylu AR; Uzunalimoglu B; Kayhan B Hepatogastroenterology; 1999; 46(25):349-52. PubMed ID: 10228819 [TBL] [Abstract][Full Text] [Related]
12. Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs. Cordeddu L; Bergvall M; Sand E; Roth B; Papadaki E; Li L; D'Amato M; Ohlsson B Scand J Gastroenterol; 2015 Mar; 50(3):291-9. PubMed ID: 25592315 [TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancer. Colombel JF; Parent M; Lescut D; Cortot A; Guillemot F; Plane C; Bonnière P; Lecomte-Houcke M; Paris JC Gastroenterol Clin Biol; 1988 Apr; 12(4):394-6. PubMed ID: 2838368 [TBL] [Abstract][Full Text] [Related]
14. [Chronic intestinal pseudo-obstruction: pathogenesis, diagnosis and therapy]. Keller J; Layer P Z Gastroenterol; 2002 Feb; 40(2):85-95. PubMed ID: 11857104 [TBL] [Abstract][Full Text] [Related]
15. Chronic idiopathic intestinal pseudo-obstruction caused by a degenerative disorder of the myenteric plexus: the use of Smith's method to define the neuropathology. Schuffler MD; Jonak Z Gastroenterology; 1982 Mar; 82(3):476-86. PubMed ID: 6172315 [TBL] [Abstract][Full Text] [Related]
16. Equine myenteric ganglionitis: a case of chronic intestinal pseudo-obstruction. Burns GA; Karcher LF; Cummings JF Cornell Vet; 1990 Jan; 80(1):53-63. PubMed ID: 2403425 [TBL] [Abstract][Full Text] [Related]
17. Diffuse lymphoplasmacytic infiltration of the small intestine with damage to nerve plexus. A cause of intestinal pseudo-obstruction. Arista-Nasr J; González-Romo M; Keirns C; Larriva-Sahd J Arch Pathol Lab Med; 1993 Aug; 117(8):812-9. PubMed ID: 8343045 [TBL] [Abstract][Full Text] [Related]
18. Surgical treatment and prognosis of chronic intestinal pseudo-obstruction in children. Kim HY; Kim JH; Jung SE; Lee SC; Park KW; Kim WK J Pediatr Surg; 2005 Nov; 40(11):1753-9. PubMed ID: 16291165 [TBL] [Abstract][Full Text] [Related]
19. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Lindberg G; Törnblom H; Iwarzon M; Nyberg B; Martin JE; Veress B Gut; 2009 Aug; 58(8):1084-90. PubMed ID: 19136514 [TBL] [Abstract][Full Text] [Related]
20. Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum. Sand E; Linninge C; Lozinska L; Egecioglu E; Roth B; Molin G; Weström B; Ekblad E; Ohlsson B BMC Res Notes; 2015 Dec; 8():824. PubMed ID: 26710832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]